Pharmaceutical nanotechnology experts are specialized scientists and researchers who focus on applying nanotechnology principles to the field of drug development and delivery. These experts leverage the unique properties of materials at the nanoscale—typically between 1 to 100 nanometers—to create innovative drug formulations that improve therapeutic efficacy, targeting, and patient compliance. Their work often involves designing nanoparticles, liposomes, nanoemulsions, and other nanocarriers that can enhance drug solubility, stability, and controlled release. By manipulating materials at such a minute scale, pharmaceutical nanotechnology experts enable drugs to cross biological barriers more effectively, reduce side effects by targeting specific tissues or cells, and develop novel treatment options for complex diseases such as cancer, neurological disorders, and infectious diseases.
The role of pharmaceutical nanotechnology experts extends beyond formulation development; they are also deeply involved in characterizing nanomaterials, assessing their safety and biocompatibility, and navigating regulatory pathways for novel nanomedicines. Their expertise requires interdisciplinary knowledge in pharmaceutics, materials science, molecular biology, and toxicology. As nanotechnology continues to revolutionize the pharmaceutical industry, these professionals play a crucial role in translating laboratory discoveries into clinically viable therapies. Their contributions not only pave the way for personalized medicine but also improve drug delivery efficiency, minimize toxicity, and ultimately enhance patient outcomes in modern healthcare.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand